SCHEMBL20205460

SCHEMBL20205460

c1ccc2c(c1)-c1ccccc1C21c2cc3c(cc2-c2c1cc(-c1cc4ccccc4o1)c1oc4ccccc4c21)C1(c2ccccc2-c2ccccc21)c1cc(-c2cc4ccccc4o2)c2oc4ccccc4c2c1-3

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAOB P27338 2/20 0.41
▸ MAOA P21397 1/20 0.41
▸ KMT2A Q03164 7/20 0.36
▸ MEN1 O00255 6/20 0.36
▸ TDP1 Q9NUW8 2/20 0.36
▸ RAB9A P51151 3/20 0.34
▸ PTPRC P08575 1/20 0.34
▸ PTPN1 P18031 1/20 0.34
▸ PDE4D Q08499 1/20 0.34
▸ HTR2C P28335 1/20 0.33
▸ NPC1 O15118 3/20 0.33
▸ SMN1; SMN2 Q16637 2/20 0.33
▸ HPGD P15428 1/20 0.33
▸ AKR1C3 P42330 1/20 0.33
▸ AKR1C2 P52895 1/20 0.33
▸ AKR1C1 Q04828 1/20 0.33
▸ POLB P06746 2/20 0.32
▸ CTDSP1 Q9GZU7 1/20 0.32
▸ ALDH1A1 P00352 1/20 0.32
▸ GAA P10253 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20205383 0.86 ALOX5 (0.36) MAOBMAOAKMT2AMEN1TDP1
SCHEMBL20205465 0.83 KMT2A (0.40) MAOBMAOAKMT2AMEN1TDP1
SCHEMBL20205651 0.83 ALOX5 (0.35) MAOAKMT2AMEN1HPGDGAA
SCHEMBL20205377 0.83 ALOX5 (0.36) TDP1RAB9AALDH1A1CYP2C9CYP2C19
SCHEMBL20205380 0.83 GPR84 (0.36) TDP1RAB9ANPC1CYP2C9CYP2C19
SCHEMBL20205334 0.82 CDC14B (0.37) KMT2AMEN1RAB9ANPC1SMN1; SMN2
SCHEMBL20205470 0.81 CDC14B (0.39) KMT2AMEN1RAB9ANPC1SMN1; SMN2
SCHEMBL20205382 0.81 CDC14B (0.34) KMT2AMEN1RAB9ANPC1SMN1; SMN2
SCHEMBL20205398 0.80 NQO1 (0.37) ALOX5BRD4CREBBP
SCHEMBL20205339 0.80 ALOX5 (0.37) KMT2AMEN1RAB9ANPC1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11453680-B2 Bisbenzofuran-fused indeno[1,2-B]fluorene derivatives and related compounds as materials for organic electroluminescent devices (OLED) MERCK PATENT GMBH (DE) 2022-09-27 — — US disclosed
EP-3544985-B1 BISBENZOFURAN-FUSED INDENO[1,2-B]FLUORENE DERIVATIVES AND RELATED COMPOUNDS AS MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES (OLED) MERCK PATENT GMBH (DE) 2021-05-12 — — EP disclosed
WO-2018095940-A1 BISBENZOFURAN-FUSED INDENO[1,2-B]FLUORENE DERIVATIVES AND RELATED COMPOUNDS AS MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES (OLED) MERCK PATENT GMBH (DE) 2018-05-31 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11453680-B2 Bisbenzofuran-fused indeno[1,2-B]fluorene derivatives and related compounds as materials for organic electroluminescent devices (OLED) OCIAD2, OCIAD1, JUND MAOB 40/4885MAOA 194/4885KMT2A 3354/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback